The Future of Biosimilars in the USA
Despite the savings and increased patient access biosimilars have brought to health care systems across Europe, the US has been surprisingly slow in their adoption. Chip Davis, President and CEO, Association…
Address: 7500 Security Boulevard, Baltimore, MD 21244
Tel: -3376
Web: http://www.cms.gov/
The Medicare and Medicaid programs were signed into law on July 30, 1965. President LBJ is pictured at the signing ceremony in Independence, Missouri at the Truman Library. Former President Truman is seated beside him. LBJ held the ceremony there to honor President Truman’s leadership on health insurance, which he first proposed in 1945. You can read LBJ’s speech at the signing ceremony and listen to his taped conversations relating to CMS programs. Key speeches and press conference excerpts from other President’s are also available. See the links in the Downloads section below.
The most significant legislative change to Medicare–called the Medicare Modernization Act or MMA–was signed into law by another President from Texas, George W. Bush, on December 8, 2003. This historic legislation adds an outpatient prescription drug benefit to Medicare and makes many other important changes. You can read his speech at the signing ceremony and see pictures of the event at the White House web site. See the links in the Downloads and Related Links Outside CMS sections below.
Oral histories of former Secretaries, Administrators, Members of Congress and other important players in the history of CMS programs are available as well as more oral histories and other CMS related-materials on the SSA web page. See the links in the Downloads and Related Links Outside CMS sections below.
Since 1965, a number of changes have been made to CMS programs. A more detailed listing of those changes is at CMS milestones. Moreover, the agencies charged with implementing the programs have changed as well. See agency history for more information about Medicare’s early days in Social Security, Medicaid’s early days in the Social and Rehabilitative Services Administration, and why they were joined together into one agency in 1977. Learn why CMS headquarters is located in Baltimore County, Maryland and how it was almost moved to the City of Baltimore. See the links in the Downloads and Related Links Outside CMS sections below.
The Centers for Medicare & Medicaid Services (CMS) ten Field offices reorganized in February 2007 moving from a geography-based structure to a Consortia structure based on the Agency’s key lines of business: Medicare health plans, Medicare financial management, Medicare fee for service operations, Medicaid and children’s health, survey & certification and quality improvement. The intent of the new structure is to improve performance through uniform issue management, consistent communication and leadership focused on achieving the Agency’s strategic action plan. Over the past year, the Field has made progress in these areas and more.
Medicare, Medicaid/CHIP, Medicare-Medicaid Coordination, Insurance Oversight, Innovation Center, Regulations and Guidance Research, Statistics, Data and Systems, Outreach and Education
Despite the savings and increased patient access biosimilars have brought to health care systems across Europe, the US has been surprisingly slow in their adoption. Chip Davis, President and CEO, Association…
Meghann Chilcott, Chief Technology/Marketing Officer at Benzer Pharmacy looks at current pharmaceutical service trends that aim to create a more perfect union among technology, medication delivery and patient care for independent…
Chester “Chip” Davis, Jr, the President and CEO of the Association for Accessible Medicines (AAM) in the US urges Congress to avoid restricting out-of-court drug patent settlements and to move away from anti-competitive…
Our contributor at large, David Crean, Managing Director for Objective Capital Partners, attended J.P. Morgan’s 2019 Health Care Investor Conference, one of the biggest events in the life sciences calendar and a…
Carla Smith is a healthcare thought leader with nearly 30 years’ experience. She champions transformational strategy, governance, and policy in the health sector, particularly in the areas of digital health…
After her son was diagnosed with SYNGAP1 – an extremely rare gene mutation – Monica founded Bridge the Gap – SYNGAP Education and Research Foundation to support families of those suffering from the…
Last week, Bristol-Myers Squibb (BMS) announced that they have entered into a definitive merger agreement under which Bristol-Myers Squibb will acquire Celgene in a cash and stock transaction with an…
PJ Brooks PhD, program director in the Office of Rare Diseases Research at the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH) in the USA, highlights…
Chester “Chip” Davis, Jr, the President and CEO of the Association for Accessible Medicines (AAM) weighs in on the issue of drug shortages in America. An uncertain environment for generic manufacturers…
David H. Crean, PhD, Managing Director for Objective Capital Partners, a leading investment banking advisory firm examines the venture investment activity in life sciences for the past year. In order…
Aditya Bhattacharji manages Eurasia Group‘s healthcare analysis and Kevin Allison is the director of geo-technology. Together they look at last week’s shock revelation of two CRISPR* babies who were born in China and…
With an increasing number of NFL players relying on potentially dangerous prescription painkillers, does the league need to relax its attitude to medical cannabis? The US National Football League…
See our Cookie Privacy Policy Here